These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 31158944)

  • 1. Heterogeneous Patterns of Striatal Dopamine Loss in Patients with Young- versus Old-Onset Parkinson's Disease: Impact on Clinical Features.
    Chung SJ; Yoo HS; Lee YH; Lee PH; Sohn YH
    J Mov Disord; 2019 May; 12(2):113-119. PubMed ID: 31158944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Presynaptic striatal dopaminergic depletion predicts the later development of freezing of gait in de novo Parkinson's disease: An analysis of the PPMI cohort.
    Kim R; Lee J; Kim Y; Kim A; Jang M; Kim HJ; Jeon B; Kang UJ; Fahn S
    Parkinsonism Relat Disord; 2018 Jun; 51():49-54. PubMed ID: 29523394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of striatal dopamine depletion on cognition in de novo Parkinson's disease.
    Chung SJ; Yoo HS; Oh JS; Kim JS; Ye BS; Sohn YH; Lee PH
    Parkinsonism Relat Disord; 2018 Jun; 51():43-48. PubMed ID: 29526657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. White matter hyperintensities as a predictor of freezing of gait in Parkinson's disease.
    Chung SJ; Lee YH; Yoo HS; Oh JS; Kim JS; Ye BS; Sohn YH; Lee PH
    Parkinsonism Relat Disord; 2019 Sep; 66():105-109. PubMed ID: 31324555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of association between dopamine transporter loss and non-motor symptoms in patients with Parkinson's disease: a detailed PET analysis of 12 striatal subregions.
    Park SB; Kwon KY; Lee JY; Im K; Sunwoo JS; Lee KB; Roh H; Ahn MY; Park S; Kim SJ; Oh JS; Kim JS
    Neurol Sci; 2019 Feb; 40(2):311-317. PubMed ID: 30415448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serial Dopamine Transporter Imaging of Nigrostriatal Function in Parkinson's Disease With Probable REM Sleep Behavior Disorder.
    Cao R; Chen X; Xie C; Hu P; Wang K
    Front Neurosci; 2020; 14():349. PubMed ID: 32425747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anxiety is associated with striatal dopamine transporter availability in newly diagnosed untreated Parkinson's disease patients.
    Erro R; Pappatà S; Amboni M; Vicidomini C; Longo K; Santangelo G; Picillo M; Vitale C; Moccia M; Giordano F; Brunetti A; Pellecchia MT; Salvatore M; Barone P
    Parkinsonism Relat Disord; 2012 Nov; 18(9):1034-8. PubMed ID: 22789824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serial dopamine transporter imaging of nigrostriatal function in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study.
    Iranzo A; Valldeoriola F; Lomeña F; Molinuevo JL; Serradell M; Salamero M; Cot A; Ros D; Pavía J; Santamaria J; Tolosa E
    Lancet Neurol; 2011 Sep; 10(9):797-805. PubMed ID: 21802993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors associated with the rate of progression of nigrostriatal degeneration in Parkinson's disease.
    Yoo HS; Kim HK; Lee HS; Yoon SH; Na HK; Kang SW; Lee JH; Ryu YH; Lyoo CH
    J Neurol; 2024 Aug; 271(8):5213-5222. PubMed ID: 38839638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An FP-CIT PET comparison of the difference in dopaminergic neuronal loss in subtypes of early Parkinson's disease.
    Song IU; Chung YA; Oh JK; Chung SW
    Acta Radiol; 2014 Apr; 55(3):366-71. PubMed ID: 23943629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presynaptic dopamine depletion determines the timing of levodopa-induced dyskinesia onset in Parkinson's disease.
    Yoo HS; Chung SJ; Chung SJ; Moon H; Oh JS; Kim JS; Hong JY; Ye BS; Sohn YH; Lee PH
    Eur J Nucl Med Mol Imaging; 2018 Mar; 45(3):423-431. PubMed ID: 29075830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can early dopamine transporter imaging serve as a predictor of Parkinson's disease progression and late motor complications?
    Djaldetti R; Rigbi A; Greenbaum L; Reiner J; Lorberboym M
    J Neurol Sci; 2018 Jul; 390():255-260. PubMed ID: 29801899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 123I-FP-CIT semi-quantitative SPECT detects preclinical bilateral dopaminergic deficit in early Parkinson's disease with unilateral symptoms.
    Filippi L; Manni C; Pierantozzi M; Brusa L; Danieli R; Stanzione P; Schillaci O
    Nucl Med Commun; 2005 May; 26(5):421-6. PubMed ID: 15838424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does dopamine deficiency affect sex-dependent prognosis in Parkinson's disease?
    Jeong SH; Lee HS; Lee PH; Sohn YH; Chung SJ
    Parkinsonism Relat Disord; 2022 Sep; 102():57-63. PubMed ID: 35961198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of dopamine transporter imaging with parkinsonian motor handicap: how close is it?
    Pirker W
    Mov Disord; 2003 Oct; 18 Suppl 7():S43-51. PubMed ID: 14531046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of striatal dopaminergic neuronal integrity with cognitive dysfunction and cerebral cortical metabolism in Parkinson's disease with mild cognitive impairment.
    Kim H; Oh M; Oh JS; Moon H; Chung SJ; Lee CS; Kim JS
    Nucl Med Commun; 2019 Dec; 40(12):1216-1223. PubMed ID: 31584466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Onset-related subtypes of Parkinson's disease differ in the patterns of striatal dopaminergic dysfunction: A positron emission tomography study.
    Liu SY; Wu JJ; Zhao J; Huang SF; Wang YX; Ge JJ; Wu P; Zuo CT; Ding ZT; Wang J
    Parkinsonism Relat Disord; 2015 Dec; 21(12):1448-53. PubMed ID: 26559130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apathy and striatal dopamine transporter levels in de-novo, untreated Parkinson's disease patients.
    Santangelo G; Vitale C; Picillo M; Cuoco S; Moccia M; Pezzella D; Erro R; Longo K; Vicidomini C; Pellecchia MT; Amboni M; Brunetti A; Salvatore M; Barone P; Pappatà S
    Parkinsonism Relat Disord; 2015 May; 21(5):489-93. PubMed ID: 25753457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Putaminal dopamine depletion in de novo Parkinson's disease predicts future development of wearing-off.
    Chung SJ; Lee Y; Oh JS; Kim JS; Lee PH; Sohn YH
    Parkinsonism Relat Disord; 2018 Aug; 53():96-100. PubMed ID: 29776864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uneven age effects of [(18)F]FP-CIT binding in the striatum of Parkinson's disease.
    Lee CS; Kim SJ; Oh SJ; Kim HO; Yun SC; Doudet D; Kim JS
    Ann Nucl Med; 2014 Nov; 28(9):874-9. PubMed ID: 25008292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.